Difference between revisions of "Cystatin A"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 46: | Line 46: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Epidermal transglutaminase|*]] | [[Category:Epidermal transglutaminase|*]] | ||
Latest revision as of 12:02, 10 March 2015
| Cystatin A | |
|---|---|
| Substrate peptide name | Cystatin A |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cornified envelope |
| Swissprot ID | P01040 |
| Reactive glutamines | Q45 |
| Reactive lysines | Not determined yet |
| Substrate sequence | VQYKTQVVAGT |
| Structure | 1GD3 |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:1353732 |
| Notes | |
